SCHEMBL3815985

SCHEMBL3815985

CC(C#N)(COc1ccc(OC(F)(F)F)cc1)NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 3/20 0.41
MRGPRX4 Q96LA9 2/20 0.39
AR P10275 3/20 0.39
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
PTK2B Q14289 1/20 0.38
CNR2 P34972 1/20 0.38
MMP2 P08253 2/20 0.37
MMP9 P14780 2/20 0.37
MMP14 P50281 2/20 0.37
ADAM17 P78536 2/20 0.37
NR3C1 P04150 1/20 0.37
PGR P06401 1/20 0.37
GRIN2B Q13224 1/20 0.37
MMP1 P03956 1/20 0.36
IDH1 O75874 1/20 0.36
CETP P11597 1/20 0.36
PLA2G1B P04054 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3820055 0.87 ALDH1A1 (0.48) ARALDH1A1MAPK1PTK2BMMP2
SCHEMBL3817722 0.87 MAPT (0.43) ARALDH1A1MAPK1PTK2BCNR2
SCHEMBL3819295 0.87 AR (0.48) ARALDH1A1MAPK1PTK2BMMP2
SCHEMBL3815007 0.86 AR (0.44) ARALDH1A1MAPK1PTK2BPGR
SCHEMBL3818288 0.84 MAPT (0.48) ARALDH1A1MAPTSMN1; SMN2
SCHEMBL3815729 0.83 HPGD (0.51) ALDH1A1MAPTSMN1; SMN2
SCHEMBL3813194 0.82 RAB9A (0.46) ARALDH1A1MAPTSMN1; SMN2
SCHEMBL3819250 0.81 NPC1 (0.42) MRGPRX4ARALDH1A1MAPK1PTK2B
SCHEMBL3819552 0.79 CYP1A2 (0.43) ARALDH1A1MAPK1PTK2BMAPT
SCHEMBL3814032 0.79 AR (0.33) LIPEARALDH1A1MAPK1PTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513802-B1 ALPHA-SULFONYLAMINO-ACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2009-08-19 EP claimed
US-7368479-B2 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION, INC. (US) 2008-05-06 US claimed
US-20050234125-A1 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION AG (CH) 2005-10-20 US claimed
EP-1513802-A1 ALPHA-SULFONYLAMINO-ACETONITRILES Syngenta Participations AG (CH) 2005-03-16 EP claimed
WO-2004000797-A1 ALPHA-SULFONYLAMINO-ACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2003-12-31 WO claimed
EP-1513802-B1 ALPHA-SULFONYLAMINO-ACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2009-08-19 EP disclosed
US-7368479-B2 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION, INC. (US) 2008-05-06 US disclosed
US-20050234125-A1 Alpha-sulfonylamino-acetonitriles SYNGENTA CROP PROTECTION AG (CH) 2005-10-20 US disclosed
EP-1513802-A1 ALPHA-SULFONYLAMINO-ACETONITRILES Syngenta Participations AG (CH) 2005-03-16 EP disclosed
WO-2004000797-A1 ALPHA-SULFONYLAMINO-ACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234125-A1 Alpha-sulfonylamino-acetonitriles C3AR1, C1S, C5 LIPE 3912/4885MRGPRX4 1084/4885AR 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.